COVAXIN demonstrated efficacy of 80.6% in Phase 3 clinical trial Bharat Biotech

This site requires Adobe Flash Player on your browser.
Please install Adobe Flash Player from here.

Uploaded by: Ani
on Wed, 03 Mar 2021 20:14:16 IST
 

COVAXIN demonstrated efficacy of 80.6% in Phase 3 clinical trial Bharat Biotech Show more

COVAXIN demonstrated efficacy of 80.6% in Phase 3 clinical trial Bharat Biotech  Show less

Click here for Embed Code
  Embed: Hide

Comments